Premium Support early detection, as infrastructure.
كمنظومة متكاملة للخليج
We represent Enable Biosciences' ADAP platform — the world's most sensitive Type 1 Diabetes autoantibody screening — across Saudi Arabia and the Gulf. Not as a product. As a program: hospitals, laboratories, pharma, and families connected into one early-detection network.
The Mandateالتفويض الحصري
Premium Support — الدعم المتميز — is the exclusive authorized representative of Enable Biosciences for the Gulf Cooperation Council. We hold the ADAP early-detection mandate for the region: one technology, one standard, one accountable partner from Riyadh to Kuwait City to Doha.
- Entity
- Premium Support (الدعم المتميز), Kingdom of Saudi Arabia
- Mandate
- Exclusive authorized representative — Enable Biosciences, Inc. (San Francisco, USA)
- Territory
- GCC — Saudi Arabia · Kuwait · Qatar · UAE · Bahrain · Oman
- Platform
- ADAP — Antibody Detection by Agglutination-PCR
- Panel
- GADA · IA-2A · IAA · ZnT8A — 4 autoantibodies, one DBS card
- Lab standard
- Developed under CLIA-certified laboratory standards
- Focus
- Type 1 Diabetes — Stage 1 & 2 detection before symptoms
The Networkشبكة الشركاء والحسابات
- SF-01 King Faisal Specialist Hospital & Research Centre Riyadh
- SF-02 King Fahd Medical City Riyadh
- SF-03 King Salman Hospital Riyadh
- SF-04 King Fahd Armed Forces Hospital Jeddah
- SF-05 National Guard Hospital Qassim
- SF-06 King Salman Armed Forces Hospital Tabuk
- SF-07 Military Forces Hospital Taif
- SF-08 Yanbu General Hospital Yanbu
- RY-01 Dasman Diabetes Institute Kuwait
- RY-02 National Guard Hospital Jeddah
- RY-03 Imam Abdulrahman Bin Faisal University Dammam
- RY-04 Sheikh Khalifa Medical City UAE
- RY-05 Sheikh Shakhbout Medical City UAE
- DR-01 Sidra Medicine Doha, Qatar
- DR-02 My Clinic Hospital Jeddah
- DR-03 Life Check Laboratory KSA
Detect & Protectاكتشف وأحمِ — برنامجنا الرائد
Detect T1D before symptoms begin.
Our consumer and family-facing screening program. One finger-prick DBS card detects all four T1D autoantibodies with 99% sensitivity — years before clinical onset. Families gain time; clinicians gain a plan; the emergency room loses a crisis.
Visit detectandprotect.premiumsupport.sa ↗How the Machine Runsآلية العمل
Find the families
First-degree relatives aged 1–45 identified through our partner hospital network across Saudi Arabia and the Gulf.
One finger-prick
DBS sample collection by Life Check — at home, in-lab, or via home visit. No cold chain, no venous draw, five minutes.
ADAP 4-plex panel
GADA, IA-2A, IAA, and ZnT8A analyzed simultaneously on a single card — PCR-amplified sensitivity no optical assay matches.
Results become a plan
Every positive result ships with a digital counseling report and a referral pathway — monitoring, staging, and Tzield eligibility via our Sanofi alignment.